UNIVERSITÉ
Faculté de médecine de l'Université d'Ankara
UNIVERSITÉ OÙ IL PREND SA EXPERTISE
Chirurgie générale de l'hôpital de formation et de recherche de Göztepe
CONGRÈS PARTICIPÉS
Congrès national de chirurgie endoscopique et laparoscopique
Congrès mondial sur les controverses en vue d'un consensus sur le diabète, l'obésité et l'hypertension
Congrès de Chirurgie Bariatrique et Métabolique
Réunions de chirurgie de Cerrahpaşa Association turque de chirurgie bariatrique
Lire la suiteUNIVERSITÉ
Faculté de médecine de l'Université d'Ankara
UNIVERSITÉ OÙ IL PREND SA EXPERTISE
Chirurgie générale de l'hôpital de formation et de recherche de Göztepe
CONGRÈS PARTICIPÉS
Congrès national de chirurgie endoscopique et laparoscopique
Congrès mondial sur les controverses en vue d'un consensus sur le diabète, l'obésité et l'hypertension
Congrès de Chirurgie Bariatrique et Métabolique
Réunions de chirurgie de Cerrahpaşa Association turque de chirurgie bariatrique
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Lire la suiteEducation:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.